Precigen wins immunotherapy approval; Pfizer sickle cell drug fails trial
Written by
BioPharma Dive
Published
0
comments
0
min
The FDA’s announcement of Papzimeos’ approval contained an unusual quote from newly reinstated CBER director Vinay Prasad. Elsewhere, Eli Lilly and Superluminal Medicines struck a deal.